[go: up one dir, main page]

BR9609148A - Método para aumentar o fluxo por eletrotransporte de polipeptídeos - Google Patents

Método para aumentar o fluxo por eletrotransporte de polipeptídeos

Info

Publication number
BR9609148A
BR9609148A BR9609148A BR9609148A BR9609148A BR 9609148 A BR9609148 A BR 9609148A BR 9609148 A BR9609148 A BR 9609148A BR 9609148 A BR9609148 A BR 9609148A BR 9609148 A BR9609148 A BR 9609148A
Authority
BR
Brazil
Prior art keywords
electrotransport
polypeptides
increase flow
increase
flow
Prior art date
Application number
BR9609148A
Other languages
English (en)
Inventor
Leslie A Holladay
Kevin R Oldenburg
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of BR9609148A publication Critical patent/BR9609148A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/20Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/635Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/815Protease inhibitors from leeches, e.g. hirudin, eglin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Radiology & Medical Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BR9609148A 1995-06-06 1996-06-06 Método para aumentar o fluxo por eletrotransporte de polipeptídeos BR9609148A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/468,275 US5747453A (en) 1995-06-06 1995-06-06 Method for increasing the electrotransport flux of polypeptides
PCT/US1996/009647 WO1996039423A2 (en) 1995-06-06 1996-06-06 A method for increasing the electrotransport flux of polypeptides

Publications (1)

Publication Number Publication Date
BR9609148A true BR9609148A (pt) 1999-02-23

Family

ID=23859150

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9609148A BR9609148A (pt) 1995-06-06 1996-06-06 Método para aumentar o fluxo por eletrotransporte de polipeptídeos

Country Status (13)

Country Link
US (2) US5747453A (pt)
JP (1) JPH11507634A (pt)
AU (1) AU6264296A (pt)
BE (1) BE1009752A5 (pt)
BR (1) BR9609148A (pt)
CA (1) CA2220060A1 (pt)
DE (1) DE19681438B4 (pt)
FR (1) FR2735133B1 (pt)
GB (1) GB2316083B (pt)
IE (1) IE960414A1 (pt)
IT (1) IT1285404B1 (pt)
NL (1) NL1003284C2 (pt)
WO (1) WO1996039423A2 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6333189B1 (en) 1996-06-06 2001-12-25 Alza Corporation Method of making an electrotransport device
EP0922467A3 (en) * 1997-12-12 2000-05-24 Takeda Chemical Industries, Ltd. Iontophoretic drug delivery
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US6949816B2 (en) * 2003-04-21 2005-09-27 Motorola, Inc. Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8465425B2 (en) * 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8480580B2 (en) 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6560471B1 (en) 2001-01-02 2003-05-06 Therasense, Inc. Analyte monitoring device and methods of use
CA2485835C (en) 2002-05-24 2018-03-06 Restoragen, Inc. Methods and dna constructs for high yield production of polypeptides
WO2003099854A2 (en) * 2002-05-24 2003-12-04 Nps Allelix Corp. Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides
WO2003100022A2 (en) * 2002-05-24 2003-12-04 Restoragen, Inc. Methods and dna constructs for high yield production of polypeptides
CA2546319A1 (en) * 2003-11-21 2005-07-28 Nps Allelix Corp. Production of glucagon like peptide 2 and analogs
USRE46830E1 (en) 2004-10-19 2018-05-08 Polypeptide Laboratories Holding (Ppl) Ab Method for solid phase peptide synthesis
US8632801B2 (en) * 2005-12-28 2014-01-21 Alza Corporation Stable therapeutic formulations

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4250878A (en) * 1978-11-22 1981-02-17 Motion Control, Inc. Non-invasive chemical species delivery apparatus and method
US4382529A (en) * 1980-12-15 1983-05-10 Drdlik Frank J Sanitary dispensing closure
CA1231306A (en) * 1983-03-03 1988-01-12 Erich Hochuli Purification of interferon
US4631211A (en) * 1985-03-25 1986-12-23 Scripps Clinic & Research Foundation Means for sequential solid phase organic synthesis and methods using the same
US4722726A (en) * 1986-02-12 1988-02-02 Key Pharmaceuticals, Inc. Method and apparatus for iontophoretic drug delivery
DE3703321A1 (de) * 1986-09-01 1988-03-10 Transcutan Gmbh Therapievorrichtung zur anwendung von elektrischem strom
AU609769B2 (en) * 1987-02-10 1991-05-09 Drug Delivery Systems Inc. Electrolytic transdermal delivery of proteins
US5080646A (en) * 1988-10-03 1992-01-14 Alza Corporation Membrane for electrotransport transdermal drug delivery
EP0482124B1 (en) * 1989-07-10 1993-12-22 The Upjohn Company Somatotropin analogs
US5516512A (en) * 1989-08-14 1996-05-14 Gist-Brocades, N.V. N- and C-terminal truncation and deletion mutants of human interleukin-3
US5240913A (en) * 1989-08-18 1993-08-31 Biogen, Inc. Inhibitors of thrombin
EP0429842B1 (en) * 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Device for the transdermal administration of protein or peptide drug
NZ237202A (en) * 1990-02-23 1994-01-26 Bristol Myers Squibb Co Composition containing beta-lactam antibiotic and cationic oligopeptide
USH1160H (en) * 1990-11-26 1993-04-06 Iontophoretic delivery of peptides
DK10191D0 (da) * 1991-01-22 1991-01-22 Novo Nordisk As Hidtil ukendte peptider
US5270170A (en) * 1991-10-16 1993-12-14 Affymax Technologies N.V. Peptide library and screening method
CA2087087C (en) * 1992-01-22 2000-07-18 Burton H. Sage, Jr. Molecules for iontophoretic delivery
US5312326A (en) * 1992-06-02 1994-05-17 Alza Corporation Iontophoretic drug delivery apparatus
US5814603A (en) * 1992-06-12 1998-09-29 Affymax Technologies N.V. Compounds with PTH activity
WO1993025197A1 (en) * 1992-06-12 1993-12-23 Affymax Technologies N.V. Compositions and methods for enhanced drug delivery
CZ315594A3 (en) * 1992-06-15 1995-07-12 Pfizer Peptide of glucagon type, insulinotropic derivatives, process of their preparation, pharmaceutical composition containing such compounds and use
EP0643981B1 (en) * 1993-09-22 2002-01-09 Hisamitsu Pharmaceutical Co., Inc. A matrix for iontophoreses
US5387189A (en) * 1993-12-02 1995-02-07 Alza Corporation Electrotransport delivery device and method of making same
DE4404168A1 (de) * 1994-02-10 1995-08-17 Hoechst Ag Hirudinderivate und Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
ITTO960495A1 (it) 1997-12-05
GB2316083A (en) 1998-02-18
DE19681438T1 (de) 1998-07-23
WO1996039423A2 (en) 1996-12-12
FR2735133B1 (fr) 1998-02-13
NL1003284A1 (nl) 1996-12-09
GB9725980D0 (en) 1998-02-04
JPH11507634A (ja) 1999-07-06
NL1003284C2 (nl) 1997-03-20
IT1285404B1 (it) 1998-06-03
ITTO960495A0 (it) 1996-06-05
US5747453A (en) 1998-05-05
DE19681438B4 (de) 2010-02-04
CA2220060A1 (en) 1996-12-12
BE1009752A5 (fr) 1997-07-01
GB2316083B (en) 2000-01-19
FR2735133A1 (fr) 1996-12-13
IE960414A1 (en) 1996-12-11
WO1996039423A3 (en) 1997-01-30
US6313092B1 (en) 2001-11-06
AU6264296A (en) 1996-12-24

Similar Documents

Publication Publication Date Title
BR9609148A (pt) Método para aumentar o fluxo por eletrotransporte de polipeptídeos
DE19681286T1 (de) Neue Kristallform von Olanzapin
DE69635284D1 (de) Neue substituierte napthopyrane
KR960704082A (ko) 저 잔자성 재료로 이루어진 하나이상의 부재의 처리방법(Method to process at least one member of low-retentivity)
BR9605758A (pt) Método aperfeiçoado para controlar o desenvolvimento de pontos compactos
DK0810923T3 (da) Fremgangsmåde til trykning
BR9609149A (pt) Modificação de drogas de polopeptídeo para aumentar o fluxo por eletrotransporte
FI951014L (fi) Syöttöveden esilämmitin
DE69602825D1 (de) Schwimmende start- und landebahn
KR900009520A (ko) 비스페놀의 연속 정제 방법
FR2571632B1 (fr) Structures de douchettes
DK75393D0 (da) Production of protein
DE59303961D1 (de) Zerlegbare Brücke
DE59302718D1 (de) Verlegbare Brücke
DE59500958D1 (de) Gliederbrücke
DE59306260D1 (de) Verlegbare Brücke
DK0820252T3 (da) Fremgangsmåde til fremstilling af en elektrode til anbringelse på huden
KR960031466U (ko) 정수기용 온수통의 구조
DE69602173D1 (de) Anwendung der gegenstrom-chromatographie zur entfaltung chemischer banken
KR940007823U (ko) 교량의 교좌장치
KR860005752U (ko) 맛사지겸용 샤워기
DE59304819D1 (de) Zerlegbare Brücke
KR960017541U (ko) 정수기의 정수 순환장치
PT101936A (pt) Elemento modular para reabilitacao de varandas
ITMI941283A0 (it) Metodo per migliorare le prestazioni dei codificatori vocali

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: DE ACORDO COM O ART. 37, INDEFIRO O PRESENTE PEDIDO, TENDO POR BASE O ART. 8O COMBINADO COM O ART.13 DA LPI 9279/96 E O ART. 229 DA LEI 9279/96, SEGUNDO REDACAO DADA PELO ARTIGO 229-A DA LEI 10196/01.

B12B Appeal against refusal [chapter 12.2 patent gazette]